Survival analysis showed that NMU/Col1a1/YAP1 expression was associated with poor overall survival, and NMU expression was the highest in pancreatic adenocarcinoma patients with pancreatitis in TCGA (Figure S5). The gene discussed is YAP1; the disease is pancreatic adenocarcinoma.